Opendoor Surges on DE Shaw 6.4% Stake: What It Really Means
DE Shaw's 6.4% Opendoor stake sends shares soaring, but it's likely a trading strategy, not a bullish bet.
Already have an account? Sign in.
DE Shaw's 6.4% Opendoor stake sends shares soaring, but it's likely a trading strategy, not a bullish bet.
Abivax shares fell after Scorpion Capital claimed its ulcerative colitis drug is toxic. The company rejected the report and reaffirmed its Phase 3 data.
CrowdStrike is reportedly in talks to acquire Zscaler in a potential $265 billion cybersecurity deal, one of the largest in the sector.
Canadian Solar shares fell sharply after a report that the solar firm and its Recurrent Energy unit are considering asset sales and a possible Chapter 11 filing.
Be the first to know when deals break, stocks move, or biotech headlines hit.